Drug Trials Snapshots: NEMLUVIO (nemolizumab-ilto)

NEMLUVIO is an interleukin-31 receptor antagonist that is indicated for the treatment of adults with prurigo nodularis. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-nemluvio